EXPRESSION OF THE COSTIMULATORY MOLECULE B7 ON MELANOMA-CELLS

被引:48
作者
HERSEY, P
SI, ZY
SMITH, MJ
THOMAS, WD
机构
[1] Oncology and Immunology Unit, Royal Newcastle Hospital, Newcastle
关键词
D O I
10.1002/ijc.2910580413
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The induction of T-cell responses against tumor cells is believed to depend on both recognition of antigen and receipt of co-stimulatory signals from interaction of ligands such as B7 with its receptors CD28 or CTLA-4 on T cells. In the present study the expression of B7 on cultured human melanoma cells was studied at the mRNA level by reverse PCR analysis and surface expression by flow cytometric analysis with monoclonal antibodies (MAbs). PCR analysis revealed mRNA for B7 in 3 of 6 (50%) cultured primary melanoma and 8 of 19 (42%) cultures of metastatic melanoma. Analysis of B7 expression by flow cytometry using the BBI MAb revealed low levels of expression in 3 of 10 melanoma that had mRNA for B7. In 2 of the latter (but not 4 other PCR(+) lines) expression could be increased by culture in GM-CSF, IL-2, IFN-gamma and IFN-alpha 2. Our results indicate that although mRNA for B7 is present in 40-50% of melanoma cell lines, expression at the protein level is at low or undetectable levels in the majority of the cell lines. Expression of B7 protein was also not detected in studies on tissue sections from 11 primary and 9 metastatic melanomas. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:527 / 532
页数:6
相关论文
共 36 条
[1]  
ANICHINI A, 1993, INT J CANCER, V53, P994
[2]   FUNCTIONAL EXPRESSION OF B7/BB1 ON ACTIVATED LYMPHOCYTES-T [J].
AZUMA, M ;
YSSEL, H ;
PHILLIPS, JH ;
SPITS, H ;
LANIER, LL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (03) :845-850
[3]   CONSTITUTIVE EXPRESSION OF B7 RESTORES IMMUNOGENICITY OF TUMOR-CELLS EXPRESSING TRUNCATED MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II MOLECULES [J].
BASKAR, S ;
OSTRANDROSENBERG, S ;
NABAVI, N ;
NADLER, LM ;
FREEMAN, GJ ;
GLIMCHER, LH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (12) :5687-5690
[4]   EXPRESSION OF TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE IN MALIGNANT MYELOBLASTS [J].
BRADSTOCK, KF ;
HEWSON, J ;
KERR, A ;
KABRAL, A ;
LEE, CH ;
HUGHES, WG .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1983, 80 (06) :800-805
[5]   INFLAMMATORY CELL INFILTRATES IN HUMAN-MELANOMA AT DIFFERENT STAGES OF TUMOR PROGRESSION [J].
BROCKER, EB ;
ZWADLO, G ;
HOLZMANN, B ;
MACHER, E ;
SORG, C .
INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (04) :562-567
[6]   SUBSETS OF HUMAN IA-LIKE MOLECULES DEFINED BY MONOCLONAL-ANTIBODIES [J].
CARREL, S ;
TOSI, R ;
GROSS, N ;
TANIGAKI, N ;
CARMAGNOLA, AL ;
ACCOLLA, RS .
MOLECULAR IMMUNOLOGY, 1981, 18 (05) :403-411
[7]   COSTIMULATION OF ANTITUMOR IMMUNITY BY THE B7 COUNTERRECEPTOR FOR THE LYMPHOCYTE-T MOLECULES CD28 AND CTLA-4 [J].
CHEN, LP ;
ASHE, S ;
BRADY, WA ;
HELLSTROM, I ;
HELLSTROM, KE ;
LEDBETTER, JA ;
MCGOWAN, P ;
LINSLEY, PS .
CELL, 1992, 71 (07) :1093-1102
[8]  
CHEN Q, 1992, INT J CANCER, V51, P1
[9]  
CROWLEY NJ, 1991, J IMMUNOL, V146, P1692
[10]   COSTIMULATION VIA VASCULAR CELL-ADHESION MOLECULE-1 INDUCES IN T-CELLS INCREASED RESPONSIVENESS TO THE CD28 COUNTER-RECEPTOR-B7 [J].
DAMLE, NK ;
KLUSSMAN, K ;
LEYTZE, G ;
OCHS, HD ;
ARUFFO, A ;
LINSLEY, PS ;
LEDBETTER, JA .
CELLULAR IMMUNOLOGY, 1993, 148 (01) :144-156